Home  |  Contact

UniProtKB/Swiss-Prot Q8NHS3: Variant p.Gly310Asp

Major facilitator superfamily domain-containing protein 8
Gene: MFSD8
Variant information

Variant position:  310
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glycine (G) to Aspartate (D) at position 310 (G310D, p.Gly310Asp).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from glycine (G) to medium size and acidic (D)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In CLN7; lysosomal localization.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  310
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  518
The length of the canonical sequence.

Location on the sequence:   ITPLTMDMYAWTQEQAVLYN  G IILAALGVEAVVIFLGVKLL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         ITPLTMDMYAWTQEQAVLYNGIILAALGVEAVVIFLGVKLL

Mouse                         LTPLTLDMYAWTQEQAVLYDGILLVAFGVEAVLVFMGVKLL

Xenopus laevis                STPLTMDMYAWTRTQAVFYNGIILAAVGVESVIVFLTVKIL

Zebrafish                     STPLSMDMFAWTRKEAVLYNGIILAAIGFESILVFLVVKVV

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 518 Major facilitator superfamily domain-containing protein 8
Transmembrane 305 – 325 Helical
Alternative sequence 237 – 518 Missing. In isoform 2.


Literature citations

The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter.
Siintola E.; Topcu M.; Aula N.; Lohi H.; Minassian B.A.; Paterson A.D.; Liu X.-Q.; Wilson C.; Lahtinen U.; Anttonen A.-K.; Lehesjoki A.-E.;
Am. J. Hum. Genet. 81:136-146(2007)
Cited for: VARIANTS CLN7 ASP-310 AND ASP-429; CHARACTERIZATION OF VARIANTS CLN7 ASP-310 AND ASP-429; SUBCELLULAR LOCATION; TISSUE SPECIFICITY;

Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis.
Kousi M.; Siintola E.; Dvorakova L.; Vlaskova H.; Turnbull J.; Topcu M.; Yuksel D.; Gokben S.; Minassian B.A.; Elleder M.; Mole S.E.; Lehesjoki A.-E.;
Brain 132:810-819(2009)
Cited for: VARIANTS CLN7 HIS-139; PRO-157; LYS-294; ASP-310 AND TRP-465;

Mutations in MFSD8/CLN7 are a frequent cause of variant-late infantile neuronal ceroid lipofuscinosis.
Aiello C.; Terracciano A.; Simonati A.; Discepoli G.; Cannelli N.; Claps D.; Crow Y.J.; Bianchi M.; Kitzmuller C.; Longo D.; Tavoni A.; Franzoni E.; Tessa A.; Veneselli E.; Boldrini R.; Filocamo M.; Williams R.E.; Bertini E.S.; Biancheri R.; Carrozzo R.; Mole S.E.; Santorelli F.M.;
Hum. Mutat. 30:E530-E540(2009)
Cited for: VARIANTS CLN7 ARG-52; LYS-294; ASP-310 AND LEU-447;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.